TTrialPathMatch Me to Trials
← Back to trials
RecruitingUrinary IncontinenceUrinary Incontinence,Stress

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

Eligible age

22+ yrs

Accepts

Women

Locations

5 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.

Sponsor: Uromedica

You may qualify if…

  • ✓ 1. Female at least 22 years old
  • ✓ 2. Diagnosed with stress urinary incontinence with primary Intrinsic Sphincter Deficiency
  • ✓ 3. Provocative pad weight of greater than 11.0 grams
  • ✓ 4. Candidate for surgical intervention
  • ✓ 5. Negative urinalysis
  • ✓ 6. Normal cystourethroscopy
  • ✓ 7. Failed at least 6 months of previous treatment(s) for stress urinary incontinence (e.g., exercise regimen, electrical stimulation, surgical procedures, etc). Note: patients may have failed prior anti-incontinence procedures for SUI (e.g., suspension, sling, or urethral bulking agent)
  • ✓ 8. Willing and able to sign informed consent and comply with trial follow-up requirements

You may not qualify if…

  • ✕ 1. Pregnant or lactating
  • ✕ 2. Life expectancy of less than 5 years
  • ✕ 3. Has uncontrolled diabetes as evidenced by HbA1c over 6.5% and fasting plasma glucose over 130 mg/dL
  • ✕ 4. Has auto-immune disease
  • ✕ 5. Undergoing radiation therapy
  • ✕ 6. Active urinary tract infection
  • ✕ 7. Detrusor instability refractory to medication
  • ✕ 8. Reduced bladder compliance as defined by a cystometrogram

Where it's recruiting

Colorado

Denver

Idaho

Meridian

Missouri

Independence

Source: ClinicalTrials.gov · NCT04248283 · last updated 2026-10-06

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI · TrialPath